Sharp Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Nov '25 Nov 17, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	119	30	-	-
Enterprise Value	116	50	-	-
Last Close Price	3.95	1.05	1.05	-
PB Ratio	60.11	7.97	-	-
P/TBV Ratio	60.11	7.97	-	-
Debt / Equity Ratio	0.91	0.51	-1.10	-1.15
Quick Ratio	4.62	5.05	0.05	0.04
Current Ratio	4.80	5.10	0.06	0.05
Return on Assets (ROA)	-	-52.06%	-95.55%	-
Return on Capital (ROIC)	-	-63.32%	-124.33%	-
Return on Capital Employed (ROCE)	-150.50%	-65.80%	36.70%	86.80%
Earnings Yield	-3.91%	-15.83%	-	-
FCF Yield	-	-17.63%	-	-
Buyback Yield / Dilution	-	-107.12%	-3028.62%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.